BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22201887)

  • 1. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt.
    Czauderna P
    Front Biosci (Elite Ed); 2012 Jan; 4(1):470-9. PubMed ID: 22201887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
    Perilongo G; Brown J; Shafford E; Brock P; De Camargo B; Keeling JW; Vos A; Philips A; Pritchard J; Plaschkes J
    Cancer; 2000 Oct; 89(8):1845-53. PubMed ID: 11042582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
    Perilongo G; Shafford E; Maibach R; Aronson D; Brugières L; Brock P; Childs M; Czauderna P; MacKinlay G; Otte JB; Pritchard J; Rondelli R; Scopinaro M; Staalman C; Plaschkes J;
    Eur J Cancer; 2004 Feb; 40(3):411-21. PubMed ID: 14746860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current chemotherapeutic approaches for hepatoblastoma.
    Watanabe K
    Int J Clin Oncol; 2013 Dec; 18(6):955-61. PubMed ID: 24052132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatoblastoma.
    Faraj W; Dar F; Marangoni G; Bartlett A; Melendez HV; Hadzic D; Dhawan A; Mieli-Vergani G; Rela M; Heaton N
    Liver Transpl; 2008 Nov; 14(11):1614-9. PubMed ID: 18975296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIOPEL trials using preoperative chemotherapy in hepatoblastoma.
    Perilongo G; Shafford E; Plaschkes J;
    Lancet Oncol; 2000 Oct; 1():94-100. PubMed ID: 11905674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).
    Czauderna P; Otte JB; Aronson DC; Gauthier F; Mackinlay G; Roebuck D; Plaschkes J; Perilongo G;
    Eur J Cancer; 2005 May; 41(7):1031-6. PubMed ID: 15862752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
    Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
    Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J; Brown J; Shafford E; Perilongo G; Brock P; Dicks-Mireaux C; Keeling J; Phillips A; Vos A; Plaschkes J
    J Clin Oncol; 2000 Nov; 18(22):3819-28. PubMed ID: 11078495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
    Hishiki T; Matsunaga T; Sasaki F; Yano M; Ida K; Horie H; Kondo S; Watanabe K; Oue T; Tajiri T; Kamimatsuse A; Ohnuma N; Hiyama E
    Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
    Häberle B; Maxwell R; Schweinitz DV; Schmid I
    Klin Padiatr; 2019 Nov; 231(6):283-290. PubMed ID: 31645068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
    Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
    J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
    Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.